Evidence map›Paper›PMID 29217666›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.

Wenli Yang, Fang C Mei, Xiaodong Cheng

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wenli YangDepartment of Integrative Biology and Pharmacology, Texas Therapeutics Institute, University of Texas Health Science Center, Houston, Texas, USA.
Fang C MeiDepartment of Integrative Biology and Pharmacology, Texas Therapeutics Institute, University of Texas Health Science Center, Houston, Texas, USA.
Xiaodong ChengDepartment of Integrative Biology and Pharmacology, Texas Therapeutics Institute, University of Texas Health Science Center, Houston, Texas, USA.
The University of Texas Health Science Center at Houston · US

Funding

Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1R01AI111464 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHENG, XIAODONG, WALKER, DAVID H · 2014 to 2018
$6.5M
Epac/cAMP-GEF, A Novel Intracellular cAMP ReceptorR01GM066170 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CHENG, XIAODONG · 2003 to 2017
$4.6M
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and TherapeuticsR35GM122536 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHENG, XIAODONG · 2017 to 2021
$1.9M
NIAID NIH HHS R01 AI111464NIGMS NIH HHS R01 GM066170NIGMS NIH HHS R35 GM122536
6 · The paper itself

Abstract

Annexins, a family of highly conserved calcium- and phospholipid-binding proteins, play important roles in a wide range of physiologic functions. Among the 12 known annexins in humans, annexin A2 (AnxA2) is one of the most extensively studied and has been implicated in various human diseases. AnxA2 can exist as a monomer or a heterotetrameric complex with S100A10 (P11) and plays a critical role in many cellular processes, including exocytosis, endocytosis, and membrane organization. At the endothelial cell surface, the (AnxA2⋅P11)

Indexed as

Annexin A2Cell MembraneGuanine Nucleotide Exchange FactorsHumansHuman Umbilical Vein Endothelial CellsPhosphoinositide Phospholipase CPlasminogenPlasminogen ActivatorsProtein BindingProtein Kinase CAnnexin A2ANXA2 protein, humanGuanine Nucleotide Exchange FactorsPhosphoinositide Phospholipase CPlasminogenPlasminogen ActivatorsProtein Kinase CRAPGEF3 protein, humancAMPfibrinolysisPKCplasminPLCɛ

Identifiers

PMID29217666
PMCPMC5893177
OpenAlexW2952484998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.